HORUS THERAPEUTICS, INC. – Trademark Portfolio

Entity Type: 03

HORUS THERAPEUTICS, INC. holds 26 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 19 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. The owner is based in Pittsford, NY.

15 Merrycreek Crossing

Pittsford, NY 14534

26 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Page 1 of 2 (26 results)

Trademark Classifications

HORUS THERAPEUTICS, INC.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (19 filings)

Scientific and technological services; industrial analysis and research services

9
Computers & Electronics (4 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

5
Pharmaceuticals (4 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does HORUS THERAPEUTICS, INC. have?

HORUS THERAPEUTICS, INC. has 26 U.S. trademarks filed with the USPTO.

What trademark classes does HORUS THERAPEUTICS, INC. file in?

HORUS THERAPEUTICS, INC. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 42 covers scientific and technological services; industrial analysis and research services.

What is HORUS THERAPEUTICS, INC.'s trademark registration success rate?

HORUS THERAPEUTICS, INC. has a 0% trademark registration rate, with 0 out of 26 resolved applications resulting in successful registration. Currently, 0 applications are pending review.